Alector, Inc.

ALEC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001653087

Price chart

Open-market purchases and sales by ALEC insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 4, 20265:45 PM ETSep 2 – Sep 4, 2026Wong-Sarad GracePrincipal Accounting OfficerSSaleCommon Stock−9.45K$2.6112−$24.67K106.02K−8.2%SEC
Sep 4, 20265:45 PM ETSep 3, 2026Berkley Neil LindsayCFO & Chief Business OfficerSSaleCommon Stock−29.25K$2.6648−$77.95K350.65K−7.7%SEC
Sep 4, 20265:45 PM ETSep 3, 2026Rosenthal ArnonChief Executive OfficerSSaleCommon Stock−72.61K$2.6647−$193.47K2.29M−3.1%SEC
Jun 3, 2026Jun 2, 2026Rosenthal ArnonChief Executive OfficerSSaleCommon Stock−87.22K$1.97−$171.82K2.37M−3.6%SEC
Jun 3, 2026Jun 2 – Jun 3, 2026Wong-Sarad GracePrincipal Accounting OfficerSSaleCommon Stock−9.18K$1.9359−$17.78K95.46K−8.8%SEC

The largest institutional positions in ALEC at the end of Q2 2026.

Institutions holding ALEC in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
TCG Crossover Management, LLC10,000,000$20.1M0.48%00.0%Unchanged
Nantahala Capital Management, LLC8,636,218$17.36M0.53%+5,820,235+206.7%Added
BlackRock, Inc.7,847,879$15.77M0.00%+106,634+1.4%Added
ACADIAN ASSET MANAGEMENT LLC4,414,345$8.86M0.01%+375,560+9.3%Added
VANGUARD CAPITAL MANAGEMENT LLC4,009,340$8.06M0.00%+330,618+9.0%Added